1. Covid-19: What is the evidence for the antiviral molnupiravir?
2. Pfizer initiates phase 2/3 study of novel covid-19 oral treatment in pediatric participants. Pfizer. Mar 2022. https://www.pfizer.com/news/press-release/press-release-detail/pfizer-initiates-phase-23-study-novel-covid-19-oral.
3. An oral SARS-CoV-2 M
pro
inhibitor clinical candidate for the treatment of COVID-19
4. Halford B. How Pfizer scientists transformed an old drug lead into a covid-19 antiviral. Chemical and Engineering News. Jan 2022. https://cen.acs.org/pharmaceuticals/drug-discovery/How-Pfizer-scientists-transformed-an-old-drug-lead-into-a-COVID-19-antiviral/100/i3.
5. Study of PF-07321332 in healthy participants. ClinicalTrials.gov. Feb 2021. https://clinicaltrials.gov/ct2/show/NCT04756531.